Company: BNBX
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001104659-25-057222
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

Applied DNA Sciences, Inc.
(the “ Company”) received written notice dated May 30, 2025 (the “ Notification Letter”) from the Listing Qualifications
Department of The Nasdaq Stock Market LLC (“ Nasdaq”) that the Company no longer satisfies the $1.00 bid price requirement
set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires
listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to
meet the minimum bid price requirement exists if the deficiency continues for a period of thirty (30) consecutive business days (collectively,
the “ Bid Price Rule”). Based on the closing bid price of the Company’s common stock, par value $0.001 per share (“ Common
Stock”), for the thirty-two (32) consecutive business days from April 14, 2025 to May 29, 2025, the Company no longer satisfies the
Bid Price Rule.

As previously disclosed, at
12:01 a. m. Eastern Time on June 2, 2025, the Company effected a 1-for-15 reverse stock split of the Common Stock in an effort to regain
compliance with the Bid Price Rule. To do so, the Company must evidence a closing bid price of at least $1.00 per share for a minimum
of ten (10), but generally not more than twenty (20), consecutive business days.

The Notification Letter further
indicated that, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for a compliance period under Nasdaq Listing
Rule 5810(c)(3)(A) due to the fact that the Company has effected a reverse stock split over the prior one-year period or has effected
one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one; accordingly, the
Company was informed that its securities were subject to delisting from Nasdaq unless the Company timely requested a hearing before the
Nasdaq Hearings Panel (the “ Panel”). Today, the Company timely requested a hearing, which request will stay any further suspension
or delisting action